Firetrail Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.1M Sell
31,530
-800
-2% -$297K 3.42% 9
2026
Q1
$9.47M Buy
32,330
+1,575
+5% +$518K 3.23% 15
2025
Q4
$10.8M Buy
30,755
+4,291
+16% +$1.45M 3.55% 11
2025
Q3
$8.49M Sell
26,464
-96
-0.4% -$29.9K 2.13% 23
2025
Q2
$10.3M Sell
26,560
-744
-3% -$299K 2.69% 20
2025
Q1
$12M Buy
27,304
+949
+4% +$381K 3.5% 12
2024
Q4
$9.76M Sell
26,355
-1,280
-5% -$536K 2.92% 18
2024
Q3
$14.4M Sell
27,635
-2,265
-8% -$1.21M 4.14% 8
2024
Q2
$16.2M Buy
29,900
+16,595
+125% +$8.77M 4.91% 6
2024
Q1
$6.9M Buy
13,305
+1,866
+16% +$928K 5.68% 6
2023
Q4
$5.57M Buy
+11,439
New +$5.29M 4.1% 14

Other funds holding ELV

Firetrail Investments's ELV Position: Q2 2026 in Review

Firetrail Investments reduced its Elevance Health (ELV) stake by 2.5% in Q2 2026, selling an estimated $297K and leaving 31,530 shares worth $12.1M. The position accounts for 3.42% of the portfolio, ranked #9.

Firetrail Investments first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $16.2M in Q2 2024. 1,593 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Firetrail Investments held 31,530 shares of Elevance Health worth $12.1M as of Q2 2026.
  • Firetrail Investments sold 800 Elevance Health shares in Q2 2026, an estimated $297K.
  • Elevance Health made up 3.42% of Firetrail Investments's portfolio in Q2 2026, its #9 holding.
  • Firetrail Investments first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Firetrail Investments's Elevance Health position peaked at $16.2M in Q2 2024.
  • 1,593 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Firetrail Investments's 13F filing for Q2 2026, filed 7 Aug 2026.